Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

January 18, 2024 5:40 (London Time)

Codexis

Youtube Subscribe

...

Sector: Life Sciences Tools & Services
Ticker: CDXS
Sentiment: 0.7575
MarketCap: 187,144,933.0
High: 2.75 Low: 2.59

Open: 2.75 Close: 2.68 Change: -0.07

We programmed an AI to read Internet. This is what it found out about Codexis.

This document will help you to evaluate Codexis without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Codexis are: Codexis, revenue, Aldevron, sign, agreement, acquire, license, and the …

Concept Map

...

Semantic Network

...

Stock Summary

Codexis reported an EPS of -$0.17 in its last earnings report, beating expectations of -0.214. Codexiss price range in the past 12 months was $2.19..

Today's Summary

Aldevron signs agreement to acquire license to Codex HiCap RNA Polymerase. The past three years for Codexis (NASDAQ:CDXS) investors has not been profitable. Codexis made a loss in the last twelve months, we think the market is probably more focussed on revenue and revenue growth. Codexis reports mixed Q3 earnings; reaffirms FY23 outlook. CFO buys 11,650 shares. Codexis announces a San Carlos facility lease that could potentially save $30M.

Today's News

Aldevron signs agreement to acquire license to Codex HiCap RNA Polymerase. The past three years for Codexis (NASDAQ:CDXS) investors has not been profitable. Codexis made a loss in the last twelve months, we think the market is probably more focussed on revenue and revenue growth. Codexis reports mixed Q3 earnings; reaffirms FY23 outlook. CFO buys 11,650 shares. Codexis announces a San Carlos facility lease that could potentially save $30M.

Stock Profile

" Codexis Documentary Showcases its Specialized Capabilities Engineering High Performance Enzymes to Enable Delivery of Novel Therapeutics. Codexis is developing its proprietary ECO Synthesis™ platform to enable the scaled manufacture of RNAi therapeutics. Codexis Inc. (CDXS) stock price today, quote & news | seeking alpha. Join the Summer Sale! Skip the content Skip to content. Codexis reported an EPS of -$0.17 in its last earnings report, beating expectations of -0.214. Codexis has 69,803,990 shares outstanding. Codexiss price range in the past 12 months was $2.19. Codexis reports second quarter 2023 financial results. Codexis reiterates its 20th financial guidance issued on July 20, 2023. Product revenues are expected to be in the range of $30 million to $35 million. Codexis delivered earnings and revenue surprises of 19.05% and 0.84% for the quarter ended June 2023. Codexis pulled back from biotherapeutics as it cuts staff by 25%. The company, which signed a lease two years ago in San Carlos, will consolidate its staff at its Redwood City headquarters. Codexis, Inc. reports financial results for the second quarter ended June 30, 2023. Codexis to Participate in Jefferies 2023 Healthcare Conference, being held June 7-9, in New York, New York."

Keywords

How much time have you spent trying to decide whether investing in Codexis? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Codexis are: Codexis, revenue, Aldevron, sign, agreement, acquire, license, and the most common words in the summary are: inc, codexis, stock, therapeutic, market, news, et, . One of the sentences in the summary was: Codexis announces a San Carlos facility lease that could potentially save $30M.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #inc #codexis #stock #therapeutic #market #news #et.

Read more →

Related Results

...
January 18, 2024 5:40 (London Time)

Codexis

Aldevron signs agreement to acquire license to Codex HiCap RNA Polymerase. The past three years for Codexis (NASDAQ:CDXS) investors has not been pro…
Sector: Life Sciences Tools & Services
Ticker: CDXS
Sentiment: 0.7575
MarketCap: 187,144,933.0
High: 2.75 Low: 2.59

Open: 2.75 Close: 2.68 Change: -0.07

Read more →
...
August 18, 2023 10:29 (London Time)

Codexis

Codexis (NASDAQ:CDXS) PT at $7.83 - defense world. Brokerages Set Codexis, Inc. (NASdaq:CDxs) PT. The major Synthetic Biology Market companies inclu…
Sector: Life Sciences Tools & Services
Ticker: CDXS
Sentiment: -0.4404
MarketCap: 117,619,729.0
High: 1.77 Low: 1.66

Open: 1.73 Close: 1.69 Change: -0.04

Read more →
...
December 21, 2023 0:10 (London Time)

Codexis

Codexis shares were up 19% at $2.48 a day after it entered into an agreement with Aldevron. Codexis CEO Stephen Dilly named a finalist for the prest…
Sector: Life Sciences Tools & Services
Ticker: CDXS
Sentiment: 0.9661
MarketCap: 216,473,616.0
High: 3.2 Low: 2.92

Open: 3.07 Close: 2.93 Change: -0.14

Read more →
...
August 07, 2023 11:35 (London Time)

Codexis

Codexis reported an EPS of -$0.17 in its last earnings report, beating expectations of -0.214. Codexiss price range in the past 12 months was $2.19.
Sector: Life Sciences Tools & Services
Ticker: CDXS
Sentiment: 0.7712
MarketCap: 220,333,466.0
High: 3.63 Low: 2.88

Open: 3.54 Close: 2.89 Change: -0.65

Read more →